Perjeta, which is pertuzumab, represents a important advancement in treating HER2-positive mammary cancer. It works by inhibiting a specific pathway that helps cancer cells multiply . Unlike some other HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 get more info receptor itself,